CA2108041A1
(en)
*
|
1991-03-29 |
1992-09-30 |
Nicholas S. Bodor |
Targeted drug delivery via mixed phosphate derivatives
|
DE4142570A1
(de)
*
|
1991-12-21 |
1993-06-24 |
Basf Ag |
Glykolaldehyd- und milchsaeurederivate, deren herstellung und verwendung
|
GB9205917D0
(en)
*
|
1992-03-18 |
1992-04-29 |
Smithkline Beecham Plc |
Pharmaceuticals
|
FR2692265B1
(fr)
|
1992-05-25 |
1996-11-08 |
Centre Nat Rech Scient |
Composes biologiquement actifs de type phosphotriesters.
|
US6020482A
(en)
*
|
1992-05-25 |
2000-02-01 |
Gosselin; Gilles |
Phosphotriester type biologically active compounds
|
US5849905A
(en)
*
|
1994-11-23 |
1998-12-15 |
Centre National De La Recherche Scientifique |
Biologically active phosphotriester-type nucleosides and methods for preparing same
|
US5770725A
(en)
*
|
1992-05-25 |
1998-06-23 |
Gosselin; Gilles |
Phosphotriester type biologically active compounds
|
FR2691463A1
(fr)
*
|
1992-05-25 |
1993-11-26 |
Centre Nat Rech Scient |
Dérivés nucléotidiques, leur préparation et leur application en thérapeutique.
|
US6057305A
(en)
|
1992-08-05 |
2000-05-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Antiretroviral enantiomeric nucleotide analogs
|
US5817647A
(en)
*
|
1993-04-01 |
1998-10-06 |
Merrell Pharmaceuticals Inc. |
Unsaturated acetylene phosphonate derivatives of purines
|
US5955591A
(en)
*
|
1993-05-12 |
1999-09-21 |
Imbach; Jean-Louis |
Phosphotriester oligonucleotides, amidites and method of preparation
|
CA2126601A1
(en)
*
|
1993-06-29 |
1994-12-30 |
Mitsubishi Chemical Corporation |
Phosphonate-nucleotide ester derivatives
|
US5798340A
(en)
|
1993-09-17 |
1998-08-25 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
US5656745A
(en)
*
|
1993-09-17 |
1997-08-12 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
JP4086314B2
(ja)
*
|
1993-09-17 |
2008-05-14 |
ギリアード サイエンシーズ, インコーポレイテッド |
ヌクレオチドアナログ
|
CA2171868A1
(en)
*
|
1993-09-17 |
1995-03-23 |
Petr Alexander |
Method for dosing therapeutic compounds
|
US5627185A
(en)
*
|
1994-11-23 |
1997-05-06 |
Gosselin; Gilles |
Acyclovir derivatives as antiviral agents
|
US5977061A
(en)
*
|
1995-04-21 |
1999-11-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
N6 - substituted nucleotide analagues and their use
|
US5717095A
(en)
*
|
1995-12-29 |
1998-02-10 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
CA2239020A1
(en)
*
|
1995-12-29 |
1997-07-10 |
Norbert W. Bischofberger |
Nucleotide analogs
|
US6093816A
(en)
|
1996-06-27 |
2000-07-25 |
Isis Pharmaceuticals, Inc. |
Cationic lipids
|
US5922695A
(en)
|
1996-07-26 |
1999-07-13 |
Gilead Sciences, Inc. |
Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability
|
DE122005000041I2
(de)
*
|
1996-07-26 |
2012-05-24 |
Gilead Sciences Inc |
Nukleotidanaloga.
|
WO1998004569A1
(en)
*
|
1996-07-26 |
1998-02-05 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
US5935946A
(en)
*
|
1997-07-25 |
1999-08-10 |
Gilead Sciences, Inc. |
Nucleotide analog composition and synthesis method
|
EP1256584B1
(de)
*
|
1997-07-25 |
2004-09-29 |
Gilead Sciences, Inc. |
Verfahren zur Herstellung von Adefovir Dipivoxil
|
ZA986614B
(en)
|
1997-07-25 |
1999-01-27 |
Gilead Sciences |
Nucleotide analog composition
|
IL133461A
(en)
*
|
1997-07-25 |
2005-05-17 |
Gilead Sciences Inc |
Adefovir dipivoxil compositions
|
AU767599B2
(en)
*
|
1998-03-06 |
2003-11-20 |
Metabasis Therapeutics, Inc. |
Novel prodrugs for phosphorus-containing compounds
|
US6312662B1
(en)
|
1998-03-06 |
2001-11-06 |
Metabasis Therapeutics, Inc. |
Prodrugs phosphorus-containing compounds
|
AU5475799A
(en)
*
|
1998-08-10 |
2000-03-06 |
Centre National De La Recherche Scientifique |
Beta-l-2'-deoxy-nucleosides for the treatment of hepatitis
|
US6444652B1
(en)
*
|
1998-08-10 |
2002-09-03 |
Novirio Pharmaceuticals Limited |
β-L-2'-deoxy-nucleosides for the treatment of hepatitis B
|
US6635278B1
(en)
|
1998-12-15 |
2003-10-21 |
Gilead Sciences, Inc. |
Pharmaceutical formulations
|
TWI230618B
(en)
*
|
1998-12-15 |
2005-04-11 |
Gilead Sciences Inc |
Pharmaceutical compositions of 9-[2-[[bis[(pivaloyloxy)methyl]phosphono]methoxy]ethyl]adenine and tablets or capsules containing the same
|
US7205404B1
(en)
*
|
1999-03-05 |
2007-04-17 |
Metabasis Therapeutics, Inc. |
Phosphorus-containing prodrugs
|
AU775332B2
(en)
*
|
1999-03-05 |
2004-07-29 |
Metabasis Therapeutics, Inc. |
Novel phosphorus-containing prodrugs
|
EP1210354A1
(de)
|
1999-09-08 |
2002-06-05 |
Metabasis Therapeutics, Inc. |
Prodrugs für leberspezifische verabreichung von arzneimitteln
|
PT1914237E
(pt)
|
1999-12-03 |
2014-09-09 |
Univ California |
Compostos antivíricos de éster fosfonato
|
JP2003531111A
(ja)
*
|
1999-12-17 |
2003-10-21 |
アライアッド・ファーマシューティカルズ・インコーポレーテッド |
プロトンポンプインヒビター
|
WO2001067772A2
(en)
*
|
2000-03-09 |
2001-09-13 |
Videoshare, Inc. |
Sharing a streaming video
|
CN100402539C
(zh)
*
|
2000-07-21 |
2008-07-16 |
吉里德科学公司 |
核苷酸膦酸酯类似物前药及其筛选和制备方法
|
MY141789A
(en)
*
|
2001-01-19 |
2010-06-30 |
Lg Chem Investment Ltd |
Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same.
|
US6818633B2
(en)
|
2001-06-29 |
2004-11-16 |
Institute Of Organic Chemistry And Biochemistry Academy Of Sciences Of The Czech Republic |
Antiviral compounds and methods for synthesis and therapy
|
JP4332496B2
(ja)
|
2002-05-13 |
2009-09-16 |
メタバシス・セラピューティクス・インコーポレイテッド |
Pmeaおよびpmpa環生成合成
|
CA2485702C
(en)
|
2002-05-13 |
2011-07-19 |
Metabasis Therapeutics, Inc. |
Novel phosphonic acid based prodrugs of pmea and its analogues
|
RU2005108601A
(ru)
*
|
2002-09-26 |
2006-01-20 |
Эл Джи Лайф Сайенсиз Лтд. (Kr) |
(+)-транс-изомеры(1-фосфонометокси-2-алкилциклопропил)метилнуклеозидные производные, способ получения их стереоизомеров и применение указанных соединений в качестве противовирусных средств
|
WO2004035577A2
(en)
*
|
2002-10-16 |
2004-04-29 |
Gilead Sciences, Inc. |
Pre-organized tricyclic integrase inhibitor compounds
|
CA2503730C
(en)
|
2002-10-31 |
2011-10-18 |
Metabasis Therapeutics, Inc. |
Cytarabine monophosphate prodrugs
|
WO2004043972A1
(fr)
*
|
2002-11-12 |
2004-05-27 |
Tianjin Kinsly Pharmaceutical Co., Ltd. |
Nouvelle forme cristalline d'adefovir dipivoxil et sa composition
|
CN105596356A
(zh)
|
2003-01-14 |
2016-05-25 |
吉里德科学公司 |
用于联合抗病毒治疗的组合物和方法
|
SG182849A1
(en)
|
2003-04-25 |
2012-08-30 |
Gilead Sciences Inc |
Antiviral phosphonate analogs
|
NZ543864A
(en)
|
2003-06-16 |
2009-10-30 |
Leuven K U Res & Dev |
Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs
|
WO2005009348A2
(en)
*
|
2003-06-25 |
2005-02-03 |
Ariad Pharmaceuticals, Inc. |
Substituted purine derivatives
|
NZ544988A
(en)
*
|
2003-07-30 |
2009-11-27 |
Gilead Sciences Inc |
Nucleobase phosphonate analogs for antiviral treatment
|
CA2537325A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Gilead Sciences, Inc. |
Aza-quinolinol phosphonate integrase inhibitor compounds
|
JP2007512359A
(ja)
*
|
2003-11-19 |
2007-05-17 |
メタバシス・セラピューティクス・インコーポレイテッド |
新規なリン含有甲状腺ホルモン様物質
|
PL1716162T3
(pl)
*
|
2003-12-30 |
2011-02-28 |
Gilead Sciences Inc |
Fosfoniany, manofosfonamidy i bisfosfonamidy do leczenia chorób wirusowych
|
JP2007517900A
(ja)
*
|
2004-01-12 |
2007-07-05 |
ギリアード サイエンシーズ, インコーポレイテッド |
ピリミジンホスホネート抗ウイルス化合物および使用方法
|
US20080153783A1
(en)
*
|
2004-01-12 |
2008-06-26 |
Gilead Sciences, Inc. |
Pyrimidyl Phosphonate Antiviral Compounds and Methods of Use
|
WO2005090370A1
(en)
|
2004-02-05 |
2005-09-29 |
The Regents Of The University Of California |
Pharmacologically active agents containing esterified phosphonates and methods for use thereof
|
AR048021A1
(es)
*
|
2004-02-17 |
2006-03-22 |
Anadys Pharmaceuticals Inc |
Derivados nucleosido fosfonato utiles en el tratamiento de infecciones de hiv.
|
PT1742642E
(pt)
*
|
2004-04-14 |
2009-01-23 |
Gilead Sciences Inc |
Análogos de fosfonato de compostos inibidores da integrase do hiv
|
AU2005254940A1
(en)
|
2004-06-08 |
2005-12-29 |
Metabasis Therapeutics, Inc. |
Lewis acid mediated synthesis of cyclic esters
|
CN100338080C
(zh)
*
|
2004-06-16 |
2007-09-19 |
山东中科泰斗化学有限公司 |
9-[2-(膦羧基甲氧基)乙基]腺嘌呤双环醇酯及其制备方法
|
UA93354C2
(ru)
*
|
2004-07-09 |
2011-02-10 |
Гилиад Сайенсиз, Инк. |
Местный противовирусный препарат
|
DK1778702T3
(da)
|
2004-07-16 |
2011-10-17 |
Gilead Sciences Inc |
Antivirale forbindelser
|
ATE505196T1
(de)
*
|
2004-07-27 |
2011-04-15 |
Gilead Sciences Inc |
Nukleosid phosphonat konjugate als anti hiv mittel
|
US20070003608A1
(en)
*
|
2005-04-08 |
2007-01-04 |
Almond Merrick R |
Compounds, compositions and methods for the treatment of viral infections and other medical disorders
|
EP1868628B1
(de)
|
2005-04-08 |
2014-06-11 |
Chimerix, Inc. |
Verbindungen, zusammensetzungen und verfahren zur behandlung von pockenvirus-infektionen
|
EP1888581A2
(de)
*
|
2005-05-16 |
2008-02-20 |
Gilead Sciences, Inc. |
Hiv-integrasehemmerverbindungen
|
MX2007014502A
(es)
|
2005-05-26 |
2008-02-07 |
Metabasis Therapeutics Inc |
Tiromimeticos para el tratamiento de enfermedades del higado graso.
|
WO2006128056A2
(en)
*
|
2005-05-26 |
2006-11-30 |
Metabasis Therapeutics, Inc. |
Novel phosphinic acid-containing thyromimetics
|
TWI375560B
(en)
|
2005-06-13 |
2012-11-01 |
Gilead Sciences Inc |
Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
|
TWI471145B
(zh)
|
2005-06-13 |
2015-02-01 |
Bristol Myers Squibb & Gilead Sciences Llc |
單一式藥學劑量型
|
CN100526315C
(zh)
|
2005-06-16 |
2009-08-12 |
浙江医药股份有限公司新昌制药厂 |
N2-喹啉或异喹啉取代的嘌呤衍生物及其制备方法和其用途
|
TW200738742A
(en)
*
|
2005-07-14 |
2007-10-16 |
Gilead Sciences Inc |
Antiviral compounds
|
TWI389908B
(zh)
*
|
2005-07-14 |
2013-03-21 |
Gilead Sciences Inc |
抗病毒化合物類
|
EP2305697A3
(de)
|
2005-07-25 |
2011-07-27 |
Intermune, Inc. |
Makrocyclische Inhibitoren der Replikation des Hepatitis-C-Virus
|
WO2007014352A2
(en)
*
|
2005-07-27 |
2007-02-01 |
Gilead Sciences, Inc. |
Antiviral phosphonate conjugates for inhibition of hiv
|
US8008287B2
(en)
*
|
2006-05-16 |
2011-08-30 |
Gilead Sciences, Inc. |
Integrase inhibitors
|
US7893264B2
(en)
*
|
2006-07-07 |
2011-02-22 |
Gilead Sciences, Inc. |
Antiviral phosphinate compounds
|
US7842672B2
(en)
|
2006-07-07 |
2010-11-30 |
Gilead Sciences, Inc. |
Phosphonate inhibitors of HCV
|
JP5599611B2
(ja)
*
|
2006-07-21 |
2014-10-01 |
ギリアード サイエンシーズ, インコーポレイテッド |
抗ウイルスプロテアーゼインヒビター
|
CA2657821A1
(en)
*
|
2006-07-21 |
2008-01-24 |
Gilead Sciences, Inc. |
Aza-peptide protease inhibitors
|
FR2908133B1
(fr)
*
|
2006-11-08 |
2012-12-14 |
Centre Nat Rech Scient |
Nouveaux analogues de nucleotides comme molecules precurseurs d'antiviraux
|
CN101190927B
(zh)
*
|
2006-11-30 |
2012-04-18 |
天津天士力集团有限公司 |
9-[2-(膦酰甲氧)乙基]腺嘌呤单特戊酰氧甲酯的制备方法
|
RU2443703C2
(ru)
|
2007-06-18 |
2012-02-27 |
Саншайн Лейк Фарма Ко., Лтд |
Бром-фенил замещенные тиазолилдигидропиримидины
|
ITMI20071594A1
(it)
*
|
2007-08-02 |
2009-02-03 |
Solmag Spa |
Forma cristallina monoidrata di adefovir dipivoxil
|
EP3085377A1
(de)
*
|
2008-01-25 |
2016-10-26 |
Chimerix, Inc. |
Verfahren zur behandlung von virusinfektionen
|
TWI444384B
(zh)
|
2008-02-20 |
2014-07-11 |
Gilead Sciences Inc |
核苷酸類似物及其在治療惡性腫瘤上的用途
|
US20110059921A1
(en)
*
|
2008-03-27 |
2011-03-10 |
Ektar Therapeutics |
Oligomer-Nitrogenous Base Conjugates
|
AR071395A1
(es)
|
2008-04-23 |
2010-06-16 |
Gilead Sciences Inc |
Analogos carba-nucleosidos 1'-sustituidos para tratamiento antiviral
|
TW201010692A
(en)
|
2008-06-19 |
2010-03-16 |
Public Univ Corp Nagoya City Univ |
Pharmaceutical composition for treatment or prevention of hbv infection
|
ES2393962T3
(es)
|
2008-07-08 |
2013-01-03 |
Gilead Sciences, Inc. |
Sales de compuestos inhibidores del VIH.
|
KR20100031045A
(ko)
*
|
2008-09-11 |
2010-03-19 |
씨제이제일제당 (주) |
아데포비어 디피복실의 정제방법
|
KR20100032803A
(ko)
*
|
2008-09-18 |
2010-03-26 |
씨제이제일제당 (주) |
아데포비어디피복실의 개선된 제조방법
|
AU2009303483A1
(en)
*
|
2008-10-15 |
2010-04-22 |
Intermune, Inc. |
Therapeutic antiviral peptides
|
JP5642766B2
(ja)
|
2009-03-26 |
2014-12-17 |
ダエウン ファーマシューティカル カンパニー リミテッド |
アデフォビルジピボキシルの新規結晶形及びその製造方法
|
EA201490853A1
(ru)
|
2009-05-13 |
2014-09-30 |
Джилид Сайэнс, Инк. |
Противовирусные соединения
|
US8614200B2
(en)
|
2009-07-21 |
2013-12-24 |
Chimerix, Inc. |
Compounds, compositions and methods for treating ocular conditions
|
ES2730805T3
(es)
|
2009-09-21 |
2019-11-12 |
Gilead Sciences Inc |
Análogos de carba-nucleósido sustituido por 2'-fluoro para el tratamiento antiviral
|
MX2012003126A
(es)
|
2009-09-21 |
2012-06-19 |
Gilead Sciences Inc |
Procesos e intermedios para la preparacion de analogos de 1'-carbonucleosidos sustituidos.
|
US7973013B2
(en)
|
2009-09-21 |
2011-07-05 |
Gilead Sciences, Inc. |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
US20110082182A1
(en)
*
|
2009-10-01 |
2011-04-07 |
Intermune, Inc. |
Therapeutic antiviral peptides
|
EP2343056A1
(de)
|
2009-12-30 |
2011-07-13 |
Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi |
Herstellung einer stabilen festen Dispersion von amorphem Adefovir dipivoxil
|
EP3216789A1
(de)
|
2010-02-12 |
2017-09-13 |
Chimerix, Inc. |
Verfahren zur behandlung von vireninfektionen
|
US20110223131A1
(en)
|
2010-02-24 |
2011-09-15 |
Gilead Sciences, Inc. |
Antiviral compounds
|
WO2011139709A2
(en)
|
2010-04-26 |
2011-11-10 |
Chimerix, Inc. |
Methods of treating retroviral infections and related dosage regimes
|
CN101812090B
(zh)
*
|
2010-05-10 |
2013-08-14 |
浙江车头制药股份有限公司 |
一种阿德福韦单酯的制备方法
|
WO2011146817A1
(en)
|
2010-05-21 |
2011-11-24 |
Gilead Sciences, Inc. |
Heterocyclic flaviviridae virus inhibitors
|
MX2012015293A
(es)
|
2010-07-02 |
2013-05-30 |
Gilead Sciences Inc |
Derivados de acido 2-quinolinil-acetico como compuestos antivirales.
|
BR112013000043A2
(pt)
|
2010-07-02 |
2019-09-24 |
Gilead Sciences Inc |
derivados de ácido naft-2-ilacético para tratar aids
|
AU2011282241B2
(en)
|
2010-07-19 |
2015-07-30 |
Gilead Sciences, Inc. |
Methods for the preparation of diasteromerically pure phosphoramidate prodrugs
|
CN101891767B
(zh)
*
|
2010-07-21 |
2012-05-23 |
浙江贝得药业有限公司 |
一种阿德福韦酯的制备方法
|
ES2524356T3
(es)
|
2010-07-22 |
2014-12-05 |
Gilead Sciences, Inc. |
Métodos y compuestos para tratar infecciones provocadas por virus Paramyxoviridae
|
WO2012032541A1
(en)
|
2010-09-06 |
2012-03-15 |
Matrix Laboratories Ltd |
"adefovir dipivoxil pseudopolymorph"
|
TW201305185A
(zh)
|
2010-09-13 |
2013-02-01 |
Gilead Sciences Inc |
用於抗病毒治療之2’-氟取代之碳-核苷類似物
|
EA026523B1
(ru)
|
2010-09-20 |
2017-04-28 |
Джилид Сайэнс, Инк. |
2'-фторзамещенные карбануклеозидные аналоги для противовирусного лечения
|
CN102093417B
(zh)
*
|
2010-11-15 |
2012-11-28 |
济南久创化学有限责任公司 |
一种可制备核苷膦酸类药物的化合物及其制备方法
|
ES2634095T3
(es)
|
2010-11-17 |
2017-09-26 |
Gilead Sciences, Inc. |
Compuestos antivíricos
|
US8841275B2
(en)
|
2010-11-30 |
2014-09-23 |
Gilead Pharmasset Llc |
2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections
|
CN104666315A
(zh)
*
|
2010-12-10 |
2015-06-03 |
西格玛制药实验有限责任公司 |
口服活性核苷酸类似物或口服活性核苷酸类似物前药的高度稳定组合物
|
ES2744587T3
(es)
|
2011-04-13 |
2020-02-25 |
Gilead Sciences Inc |
Análogos de N-nucleósido de pirimidina 1-sustituidos para un tratamiento antiviral
|
ES2707997T3
(es)
|
2011-04-21 |
2019-04-08 |
Gilead Sciences Inc |
Compuestos de benzotiazol y su uso farmacéutico
|
PT2729448E
(pt)
|
2011-07-06 |
2015-12-02 |
Gilead Sciences Inc |
Compostos para o tratamento de vih
|
MX336627B
(es)
|
2011-08-16 |
2016-01-26 |
Gilead Sciences Inc |
Hemifumarato de tenofovir alafenamida.
|
LT2907816T
(lt)
|
2011-11-16 |
2018-09-10 |
Gilead Pharmasset Llc |
Kondensuoti imidazolilai, kaip priešvirusiniai junginiai
|
JP6113185B2
(ja)
|
2011-12-22 |
2017-04-12 |
ジェロン・コーポレーションGeron Corporation |
テロメラーゼ基質およびテロメア長作用因子としてのグアニンアナログ
|
WO2013103724A1
(en)
|
2012-01-04 |
2013-07-11 |
Gilead Sciences, Inc. |
2- (tert - butoxy) -2- (7 -methylquinolin- 6 - yl) acetic acid derivatives for treating aids
|
WO2013103738A1
(en)
|
2012-01-04 |
2013-07-11 |
Gilead Sciences, Inc. |
Napthalene acetic acid derivatives against hiv infection
|
CN106749272B
(zh)
|
2012-03-13 |
2019-08-30 |
吉利德科学公司 |
用于抗病毒治疗的2’-取代的卡巴-核苷类似物
|
ES2571479T3
(es)
|
2012-04-20 |
2016-05-25 |
Gilead Sciences Inc |
Derivados del ácido benzotiazol-6-il acético y su uso para tratar una infección por VIH
|
EP2846788A1
(de)
|
2012-05-11 |
2015-03-18 |
Akron Molecules AG |
Verwendung von verbindungen zur schmerzbehandlung
|
US20130309196A1
(en)
|
2012-05-16 |
2013-11-21 |
Gilead Sciences, Inc. |
Antiviral compounds
|
US9079887B2
(en)
|
2012-05-16 |
2015-07-14 |
Gilead Sciences, Inc. |
Antiviral compounds
|
CN103665043B
(zh)
|
2012-08-30 |
2017-11-10 |
江苏豪森药业集团有限公司 |
一种替诺福韦前药及其在医药上的应用
|
CN102977146B
(zh)
*
|
2012-11-20 |
2016-04-20 |
广东肇庆星湖生物科技股份有限公司 |
一种腺嘌呤衍生物的合成方法
|
US9233974B2
(en)
|
2012-12-21 |
2016-01-12 |
Gilead Sciences, Inc. |
Antiviral compounds
|
EA201892769A3
(ru)
*
|
2013-03-15 |
2019-08-30 |
Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния |
Сложные диэфиры ациклических нуклеозидфосфонатов
|
CN110156838A
(zh)
*
|
2013-05-14 |
2019-08-23 |
北京美倍他药物研究有限公司 |
磷酸/膦酸衍生物及其医药用途
|
WO2015096697A1
(zh)
*
|
2013-12-23 |
2015-07-02 |
四川海思科制药有限公司 |
非环核苷磷酸酯类衍生物及其制备方法与在医学上的应用
|
CN106061984A
(zh)
|
2014-02-13 |
2016-10-26 |
配体药物公司 |
前药化合物及其用途
|
US10202353B2
(en)
|
2014-02-28 |
2019-02-12 |
Gilead Sciences, Inc. |
Therapeutic compounds
|
CN105518012B
(zh)
*
|
2014-06-25 |
2018-03-02 |
四川海思科制药有限公司 |
一种取代的氨基酸硫酯类化合物、其组合物及应用
|
EP3164136A4
(de)
|
2014-07-02 |
2018-04-04 |
Ligand Pharmaceuticals, Inc. |
Prodrug-verbindungen und verwendungen davon
|
PL3194411T3
(pl)
|
2014-09-15 |
2022-06-20 |
The Regents Of The University Of California |
Analogi nukleotydów
|
TWI687432B
(zh)
|
2014-10-29 |
2020-03-11 |
美商基利科學股份有限公司 |
絲狀病毒科病毒感染之治療
|
GB201509431D0
(en)
*
|
2015-06-01 |
2015-07-15 |
Equigerminal Sa |
Antiviral composition
|
WO2017048956A1
(en)
|
2015-09-15 |
2017-03-23 |
The Regents Of The University Of California |
Nucleotide analogs
|
ES2909419T3
(es)
|
2015-09-16 |
2022-05-06 |
Gilead Sciences Inc |
Métodos para el tratamiento de infecciones por coronaviridae
|
CN105294762A
(zh)
*
|
2015-11-13 |
2016-02-03 |
中国药科大学 |
阿德福韦酯杂质的制备方法
|
CN106800573B
(zh)
*
|
2015-11-25 |
2020-03-10 |
四川海思科制药有限公司 |
一种核苷酸膦酸酯一水合物及其制备方法和在医药上的应用
|
PL3347352T3
(pl)
|
2016-08-19 |
2019-12-31 |
Gilead Sciences, Inc. |
Związki terapeutyczne użyteczne do profilaktycznego lub terapeutycznego leczenia zakażenia wirusem HIV
|
US10449208B2
(en)
*
|
2016-08-25 |
2019-10-22 |
Merck Sharp & Dohme Corp. |
Antiviral prodrugs of tenofovir
|
EP3519409A1
(de)
|
2016-09-28 |
2019-08-07 |
Gilead Sciences, Inc. |
Benzothiazol-6-yl-essigsäure-derivate und deren verwendung zur behandlung von hiv-infektionen
|
JP2020500199A
(ja)
|
2016-11-21 |
2020-01-09 |
バイキング・セラピューティクス・インコーポレイテッド |
グリコーゲン蓄積症の治療方法
|
EP3372227A1
(de)
|
2017-03-06 |
2018-09-12 |
MH10 Spolka z ograniczona odpowiedzialnoscia |
Tablettenformulierung von adefovir dipivoxil
|
EP3595672B1
(de)
|
2017-03-14 |
2023-09-06 |
Gilead Sciences, Inc. |
Verbindungen zur verwendung in verfahren zur behandlung von coronavirus-infektionen bei katzen
|
JP2020518578A
(ja)
|
2017-05-01 |
2020-06-25 |
ギリアード サイエンシーズ, インコーポレイテッド |
(S)−2−エチルブチル2−(((S)−(((2R,3S,4R,5R)−5−(4−アミノピロロ[2,1−f][1,2,4]トリアジン−7−イル)−5−シアノ−3,4−ジヒドロキシテトラヒドロフラン−2−イル)メトキシ)(フェノキシ)ホスホリル)アミノ)プロパノエートの結晶形態
|
EA201992703A1
(ru)
|
2017-06-05 |
2020-04-15 |
Вайкинг Терапьютикс, Инк. |
Композиции для лечения фиброза
|
TW201919648A
(zh)
|
2017-07-11 |
2019-06-01 |
美商基利科學股份有限公司 |
用於治療病毒感染之含rna聚合酶抑制劑與環糊精的組合物
|
ES2969496T3
(es)
|
2017-08-01 |
2024-05-20 |
Gilead Sciences Inc |
Formas cristalinas de ((S)-((((2R,5R)-5-(6-amino-9H-purin-9-il)-4-fluoro-2,5-dihidrofuran-2- il)oxi)metil)(fenoxi)fosforil)-L-alaninato de etilo para tratar infecciones virales
|
AR112412A1
(es)
|
2017-08-17 |
2019-10-23 |
Gilead Sciences Inc |
Formas de sal de colina de un inhibidor de la cápside del vih
|
AR112413A1
(es)
|
2017-08-17 |
2019-10-23 |
Gilead Sciences Inc |
Formas sólidas de un inhibidor de la cápside del vih
|
CA3087932A1
(en)
|
2018-01-09 |
2019-07-18 |
Ligand Pharmaceuticals, Inc. |
Acetal compounds and therapeutic uses thereof
|
JP7083398B2
(ja)
|
2018-02-15 |
2022-06-10 |
ギリアード サイエンシーズ, インコーポレイテッド |
ピリジン誘導体およびhiv感染を処置するためのその使用
|
CA3175557A1
(en)
|
2018-02-16 |
2019-08-22 |
Gilead Sciences, Inc. |
Methods and intermediates for preparing a therapeutic compound useful in the treatment of retroviridae viral infection
|
CN112135832A
(zh)
|
2018-03-22 |
2020-12-25 |
维京治疗公司 |
化合物的晶型和制备化合物的晶型的方法
|
EP3823621A1
(de)
|
2018-07-16 |
2021-05-26 |
Gilead Sciences, Inc. |
Capsidinhibitoren zur behandlung von hiv
|
WO2021074443A1
(en)
|
2019-10-17 |
2021-04-22 |
Ai-Biopharma |
Anti-viral and hepatic-targeted drugs
|
AU2020391466B2
(en)
|
2019-11-26 |
2024-05-23 |
Gilead Sciences, Inc. |
Capsid inhibitors for the prevention of HIV
|
CA3163424A1
(en)
|
2020-01-27 |
2021-08-05 |
Gilead Sciences, Inc. |
Methods for treating sars cov-2 infections
|
WO2021183750A2
(en)
|
2020-03-12 |
2021-09-16 |
Gilead Sciences, Inc. |
Methods of preparing 1'-cyano nucleosides
|
AU2021251689A1
(en)
|
2020-04-06 |
2022-11-17 |
Gilead Sciences, Inc. |
Inhalation formulations of 1'-cyano substituted carbanucleoside analogs
|
AU2021281351A1
(en)
|
2020-05-29 |
2023-01-19 |
Gilead Sciences, Inc. |
Remdesivir treatment methods
|
CA3187821A1
(en)
|
2020-06-24 |
2021-12-30 |
Gilead Sciences, Inc. |
1'-cyano nucleoside analogs and uses thereof
|
EP4172157A1
(de)
|
2020-06-25 |
2023-05-03 |
Gilead Sciences, Inc. |
Capsid-inhibitoren zur behandlung von hiv
|
MX2023002195A
(es)
|
2020-08-27 |
2023-03-03 |
Gilead Sciences Inc |
Compuestos y metodos para el tratamiento de infecciones virales.
|
CN117460734A
(zh)
|
2021-05-21 |
2024-01-26 |
吉利德科学公司 |
作为寨卡病毒抑制剂的五环衍生物
|
CN113880883A
(zh)
*
|
2021-11-11 |
2022-01-04 |
奥锐特药业股份有限公司 |
核苷类磷酸酯前药的制备方法
|
WO2023102239A1
(en)
|
2021-12-03 |
2023-06-08 |
Gilead Sciences, Inc. |
Therapeutic compounds for hiv virus infection
|
EP4320128A1
(de)
|
2022-03-02 |
2024-02-14 |
Gilead Sciences, Inc. |
Verbindungen und verfahren zur behandlung von virusinfektionen
|